Close Menu
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
What's Hot

Google introduces faster, cheaper image generation with Nano Banana 2 Lite

June 30, 2026

Blue Origin pivots to redesigned launch pad after New Glenn explosion

June 30, 2026

Congressman Tom Keene says he missed several months of Congress due to depression

June 30, 2026
Facebook X (Twitter) Instagram
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Facebook X (Twitter) Instagram
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Home » Stocks with the biggest price movements at noon: COIN, ANET, CVX, HAL
World

Stocks with the biggest price movements at noon: COIN, ANET, CVX, HAL

Editor-In-ChiefBy Editor-In-ChiefJanuary 5, 2026No Comments3 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email


Check out the companies making the biggest moves this midday: Oil stocks — Shares of major U.S. oil companies soared as they are seen as beneficiaries of the country’s rebuilding of its energy infrastructure following the U.S. operation in Venezuela that led to the arrest of Venezuelan leader Nicolás Maduro. Chevron, which already has a presence there, rose 5%, and Exxon Mobil rose 2%. Oilfield services giant Halliburton soared 11%. Coinbase — The cryptocurrency exchange rose 7% after Goldman Sachs upgraded it from neutral to buy. “COIN’s scale and brand recognition continues to drive above-average revenue growth and market share expansion, and is complemented by its best-in-class (customer acquisition costs)…and recent product rollouts that increase its competitiveness across COIN, particularly in new structural growth products,” the bank wrote. Okta — The access management platform company’s stock rose about 6%. Okta announced a $1 billion stock repurchase program on Monday morning, effective immediately. Arista Networks — Shares rose more than 2% after Piper Sandler upgraded the company from neutral to overweight. “Based on our research, we believe 2026 will be a ‘year of refreshment’ that will benefit hardware vendors like Arista,” the company said. Estée Lauder — The cosmetics company rose nearly 2% on strong market performance buys on the back of Raymond James Co.’s upgrade. The company also named the company one of its top picks for 2026 as it executes a turnaround. Domino’s Pizza — The pizza chain’s stock price fell more than 3% following a downgrade by TD Cowen. Analyst Andrew Charles lowered his rating on the company from buy to hold and lowered his 2026 U.S. same-store sales forecast to 2.5% from 3%, citing headwinds from weakness in the pizza delivery segment. Phillips 66 — The oil refiner rose 7% after agreeing to buy assets and related infrastructure from Lindsay Refinery for an undisclosed sum, which will be liquidated by formal receivership. The business will be integrated into Britain’s Philips’ Humber refinery Mobileye — Self-driving car technology maker Mobileye rose more than 3% after Barclays upgraded its rating from equal weight to overweight. The bank cited a “favorable” risk/reward rationale for the rating change. QXO — The roofing and construction products distributor rose 19% after securing a $1.2 billion preferred equity investment led by private equity giant Apollo. Duolingo — The language teaching app rose 7% after Bank of America upgraded it to Buy from Neutral. “We believe (Duolingo’s) value proposition as an entertainment product is not reflected in our growth projections,” BofA said in a note. Zenas BioPharma — The Massachusetts biotech company plunged more than 50% after announcing it was no longer eligible for milestone payments with Royalty Pharma Investments under a prior agreement related to its INDIGO trial for immunoglobulin G4-related diseases. —CNBC’s Michelle Fox, Scott Schnipper, Nick Wells and Darla Mercado contributed reporting.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor-In-Chief
  • Website

Related Posts

Oil prices: President Trump and Iran send mixed messages regarding talks in Qatar

June 30, 2026

IRS: Donations to Trump accounts are not subject to gift tax reporting

June 30, 2026

Micron stock decline: Bulls and bears position in chip trading

June 30, 2026
Add A Comment

Comments are closed.

News

Birthright citizenship ruling: Reactions from U.S. officials, lawmakers and advocates | Immigration News

By Editor-In-ChiefJune 30, 2026

The backlash comes after the U.S. Supreme Court ruled against President Donald Trump’s administration, which…

US Supreme Court challenges President Trump’s birthright citizenship suspension order | Donald Trump News

June 30, 2026

U.S. Supreme Court hands President Trump a 3-1 defeat in landmark ruling: What we know | Courtroom News

June 30, 2026
Top Trending

Google introduces faster, cheaper image generation with Nano Banana 2 Lite

By Editor-In-ChiefJune 30, 2026

Google on Tuesday released Nano Banana 2 Lite, the latest version of…

Amazon follows OpenAI and Anthropic in launching new $1 billion FDE organization

By Editor-In-ChiefJune 30, 2026

As businesses struggle to integrate AI, they are increasingly prepared to bring…

Podcasting platform Riverside gets into the newsletter publishing game

By Editor-In-ChiefJune 30, 2026

Riverside, a maker of video and podcast recording tools, is giving users…

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Welcome to WhistleBuzz.com (“we,” “our,” or “us”). Your privacy is important to us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://whistlebuzz.com/ (the “Site”). Please read this policy carefully to understand our views and practices regarding your personal data and how we will treat it.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Facebook X (Twitter) Instagram Pinterest
  • Home
  • Advertise With Us
  • Contact US
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
  • About US
© 2026 whistlebuzz. Designed by whistlebuzz.

Type above and press Enter to search. Press Esc to cancel.